News
CirCode Biomed gets US FDA clearance for IND application of HM2002, the world's first circular RNA drug being administrated in patients: Shanghai, China Monday, June 2, 2025, 18:0 ...
DRI seizes 9.72 kg methamphetamine tablets in Mizoram, one person arrested: Our Bureau, New Delhi Monday, June 2, 2025, 17:15 Hrs [IST] The Directorate of Revenue Intelligence (DR ...
Auron Therapeutics begins patient dosing in phase 1 trial of AUTX-703 in advanced hematologic malignancies: Newton, Massachusetts Monday, June 2, 2025, 16:00 Hrs [IST] Auron Thera ...
KKR, a leading global investment firm, and Manipal Education and Medical Group (MEMG), a major diversified conglomerate in India for medical education and healthcare announced a $600 million financing ...
Our Bureau, New Delhi Monday, June 2, 2025, 16:50 Hrs [IST] The Pharmacy Council of India (PCI) announced that Jashubhai Hi ...
Our Bureau, Mumbai Monday, June 2, 2025, 16:15 Hrs [IST] ...
AIxMed, Lumea ink partnership to enhance digital pathology platform with AI-powered urine cytology solution: Santa Clara, California Monday, June 2, 2025, 17:00 Hrs [IST] AIxMed, ...
Researchers identify diagnostic aid to determine risk of diabetic foot ulcer recurrence: Bethesda, Maryland Monday, June 2, 2025, 15:00 Hrs [IST] A research team funded by the Nat ...
Merck inks licence agreement with Teijin Pharma for investigational antibody candidate targeting tau
Merck inks licence agreement with Teijin Pharma for investigational antibody candidate targeting tau: Kenilworth, New Jersey Monday, May 29, 2017, 10:00 Hrs [IST] Merck, known as ...
PU Karthikeyan is new director-in-charge of drug control in Tamil Nadu: Our Bureau, Chennai Monday, June 2, 2025, 14:10 Hrs [IST] PU Karthikeyan, the joint director at the drug co ...
Ministry of Ayush launches portal to address issues of misleading advertisements and ADR: Our Bureau, New Delhi Monday, June 2, 2025, 14:15 Hrs [IST] The Ministry of Ayush has lau ...
Merck’s investigational KRAS G12C inhibitor, MK-1084 shows antitumor activity in phase 1 trial: Rahway, New Jersey Monday, June 2, 2025, 14:00 Hrs [IST] Merck, known as MSD outs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results